Literature DB >> 13952556

Distribution and metabolism of salicyl-azo-sulfapyridine. II. A study with S35-salicyl-azo-sulfapyridine and S35-sulfapyridine.

A HANNGREN, E HANSSON, N SVARTZ, S ULLBERG.   

Abstract

Entities:  

Keywords:  SULFONAMIDES

Mesh:

Substances:

Year:  1963        PMID: 13952556     DOI: 10.1111/j.0954-6820.1963.tb17422.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


× No keyword cloud information.
  8 in total

1.  Whole body sagittal technique in mice employing a new bio-autographic method: its utility for the evaluation of the body distribution of antibacterial drugs.

Authors:  E Tubaro; M J Bulgini
Journal:  Experientia       Date:  1967-04-15

2.  Faecal flora of patients with ulcerative colitis during treatment with salicylazosulphapyridine.

Authors:  E M Cooke
Journal:  Gut       Date:  1969-07       Impact factor: 23.059

3.  Effects of sulfasalazine on selected lymphocyte subpopulations in vivo and in vitro.

Authors:  W R Thayer; C Charland; C E Field
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

Review 4.  Clinical pharmacokinetics of sulphasalazine.

Authors:  K M Das; R Dubin
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

6.  The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients.

Authors:  K M Das; M A Eastwood; J P McManus; W Sircus
Journal:  Gut       Date:  1973-08       Impact factor: 23.059

Review 7.  Pharmacological and biochemical actions of sulphasalazine.

Authors:  J R Hoult
Journal:  Drugs       Date:  1986       Impact factor: 9.546

8.  Mechanism of action of 5-arninosalicylic acid.

Authors:  N A Punchard; S M Greenfield; R P Thompson
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.